Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Clinical Trial of the Use of Antioxidants and Pentoxifylline as Adjuvant Therapy to Standard Therapy in Patients With and Without Septic Shock Secondary to COVID-19 Severe Pneumonia

NCT04570254 is registered in ClinicalTrials.gov with Unidad Temporal COVID-19 en Centro Citibanamex as lead sponsor.

NCT NCT04570254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04570254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Clinical Trial of the Use of Antioxidants and Pentoxifylline as Adjuvant Therapy to Standard Therapy in Patients With and Without Septic Shock Secondary to COVID-19 Severe Pneumonia
Lead sponsor
Unidad Temporal COVID-19 en Centro Citibanamex
Phase
Not applicable
Overall status
Completed
Start date
August 19, 2020
Completion date
December 1, 2020
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid19, oxidative stress, pneumonia, viral